Monkeypox update

Sep. 2022Important Notices
Monkeypox is a rare infectious disease caused by the monkeypox virus. Although we are seeing an outbreak of cases across the U.S. and the world this summer, it remains rare. The illness associated with monkeypox can include fever, fatigue, body aches, and swollen lymph nodes. The most prominent feature of the illness is a rash, which can occur with or without the other symptoms. The rash starts as spots that progress to fluid-filled bumps and eventually break open and leave a scab. Monkeypox is spread by close contact with an infected individual. This close contact can be during sexual activity, but monkeypox is not a sexually transmitted infection.

Vaccines and treatments for monkeypox are available in the community and may be recommended for those who have tested positive or had close, prolonged contact with an infected individual. If you have further questions about monkeypox, you can find more information at cdc.gov/poxvirus/monkeypox/clinicians/index.html.

Recent Announcements

Voluntary nationwide recall: Ocaliva (Intercept – September)

Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).
Oct. 2025Pharmacy Updates

HelpScript service helps patients enroll in manufacturer copay assistance programs

End-to-end provider support helps ensure a smooth submission process
Oct. 2025Important Notices

Important announcement – Telehealth submissions

As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.
Sep. 2025Important Notices